4/1
02:22 pm
drrx
DURECT Corporation (NASDAQ:DRRX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
DURECT Corporation (NASDAQ:DRRX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
4/1
10:15 am
drrx
DURECT Co. (NASDAQ: DRRX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $5.00 price target on the stock.
Low
Report
DURECT Co. (NASDAQ: DRRX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $5.00 price target on the stock.
3/28
11:03 pm
drrx
DURECT Co. (NASDAQ: DRRX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
DURECT Co. (NASDAQ: DRRX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
3/28
08:24 am
drrx
DURECT Co. (NASDAQ: DRRX) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
High
Report
DURECT Co. (NASDAQ: DRRX) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
3/27
06:24 pm
drrx
Durect (DRRX) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]
Medium
Report
Durect (DRRX) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]
3/27
04:09 pm
drrx
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
3/27
04:01 pm
drrx
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Medium
Report
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
3/20
04:39 pm
drrx
DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update [Yahoo! Finance]
Low
Report
DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update [Yahoo! Finance]
3/20
04:30 pm
drrx
DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update
Low
Report
DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update
3/19
02:09 am
drrx
DURECT Co. (NASDAQ: DRRX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
DURECT Co. (NASDAQ: DRRX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
3/11
02:05 am
drrx
DURECT Co. (NASDAQ: DRRX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Neutral
Report
DURECT Co. (NASDAQ: DRRX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
3/4
07:51 am
drrx
DURECT and Charles River enter agreement for alzet in U.S., Canada [Seeking Alpha]
Low
Report
DURECT and Charles River enter agreement for alzet in U.S., Canada [Seeking Alpha]
3/4
07:17 am
drrx
DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET® Product Line in U.S. and Canada [Yahoo! Finance]
Low
Report
DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET® Product Line in U.S. and Canada [Yahoo! Finance]
3/4
07:00 am
drrx
DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET® Product Line in U.S. and Canada
High
Report
DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET® Product Line in U.S. and Canada
3/3
02:06 am
drrx
DURECT Co. (NASDAQ: DRRX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
DURECT Co. (NASDAQ: DRRX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
2/28
10:12 am
drrx
Long-Acting Drug Delivery Technologies and Services Market Predicted to Reach $36.82 Billion by 2033, as Asia-Pacific Emerges with Highest CAGR [Yahoo! Finance]
Low
Report
Long-Acting Drug Delivery Technologies and Services Market Predicted to Reach $36.82 Billion by 2033, as Asia-Pacific Emerges with Highest CAGR [Yahoo! Finance]
2/24
02:04 am
drrx
DURECT Co. (NASDAQ: DRRX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
DURECT Co. (NASDAQ: DRRX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
2/16
10:04 pm
drrx
DURECT Co. (NASDAQ: DRRX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
DURECT Co. (NASDAQ: DRRX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
2/7
06:53 pm
drrx
DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference [Yahoo! Finance]
Medium
Report
DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference [Yahoo! Finance]
2/7
06:48 pm
drrx
DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Medium
Report
DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference